Form4insider filings, from the source

Insider holders · CIK 0001557421

Ignyta, Inc. · RXDX

Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity

InsiderDirect sharesIndirect sharesTotal reportedLast report (ET)From
City Hill Venture Partners I, LLC10% Owner3,350,000—3,350,000Mar 21, 2016 · 12:48 pm EDTForm 4
CEPHALON INC10% Owner3,000,000—3,000,000Mar 27, 2015 · 2:30 pm EDTForm 3
TEVA PHARMACEUTICAL INDUSTRIES LTD10% Owner3,000,000—3,000,000Mar 27, 2015 · 2:30 pm EDTForm 3
Matthew OnaitisGeneral Counsel and Secretary46,400—46,400Jan 11, 2016 · 6:28 pm ESTForm 4
James A BristolDirector21,667021,667Feb 12, 2018 · 3:26 pm ESTForm 4
Robert WildSr. VP, Research and CSO13,200—13,200Jan 11, 2016 · 6:32 pm ESTForm 4
Igor BilinskyGM, Immuno-Oncology/SVP Sp Ops6,960—6,960Jan 11, 2016 · 6:42 pm ESTForm 4
William R McCarthyChief Business Officer0—0Feb 12, 2018 · 3:34 pm ESTForm 4
Valerie Denise Harding StartSVP, Chemistry, Mfg & Controls0—0Feb 12, 2018 · 3:35 pm ESTForm 4
Jacob ChackoChief Financial Officer0—0Feb 12, 2018 · 3:28 pm ESTForm 4
Zachary HornbyChief Operating Officer0—0Feb 12, 2018 · 3:31 pm ESTForm 4
Pratik S MultaniChief Medical Officer0—0Feb 12, 2018 · 3:34 pm ESTForm 4
Alexander W. CasdinDirector000Feb 12, 2018 · 3:27 pm ESTForm 4
Christian V KuhlenGeneral Counsel and Secretary0—0Feb 12, 2018 · 3:32 pm ESTForm 4
James L FreddoDirector0—0Feb 12, 2018 · 3:30 pm ESTForm 4
Jonathan E LimPresident, CEO & Director000Feb 12, 2018 · 3:33 pm ESTForm 4

Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.